Redefining Phenotyping for Clinical Advancements and Variant Prioritization
FDNA’s CEO, Dekel Gelbman, joined two distinguished members of the genetics community—Dr. John Carey (University of Utah) and Dr. Christine Read more
FDNA Insights
2018 Year in Review
It was an exciting 2018 for FDNA, as we continued on our path to bring AI-based phenotyping technologies to clinicians, Read more
Personalizing Medicine with Artificial Intelligence and Facial Analysis
Personalizing Medicine with Artificial Intelligence and Facial Analysis Presented by Omar Abdul-Rahman, MD, University of Nebraska Medical Center Precision Medicine Read more
FDNA and Microsoft Collaborate to Enhance Genomics Technology Through AI
FDNA and Microsoft Genomics are working together to integrate the most advanced Artificial Intelligence solutions to support clinical genomics. Read more
What to Do and See at ASHG 2018
San Diego, CA – The FDNA team is excited to be back at the American Society of Human Genetics (ASHG) Read more
Moms on a Mission for Rare Disease Advocacy
Change in healthcare comes in many forms. Some say it’s legislature. Some say it’s technology. Some will cite time and Read more
The Genomics Collaborative: How to Design the Future of Health—Together
ThinkGenetic recently hosted a panel discussion among researchers involved in the Genomics Collaborative, an FDNA initiative connecting researchers, clinicians, Read more
AI in Healthcare: Separating the Hype from the Hope
FDNA’s CEO Dekel Gelbman recently spoke to hundreds of leaders during the Stanford Big Data in Precision Health Summit. The Read more
“Where are the limits?”
Big data, next-generation phenotyping, and the possibilities for precision medicine This post is based on a presentation given at the Read more
FDNA and Face2Gene Featured at ESHG
A flock of researchers from around the globe shared their findings in dysmorphology and molecular genetics at this year’s Read more
What to Do and See at ESHG
The European Society of Human Genetics (ESHG) 42nd Annual Meeting 2018 MiCo – Milano Congressi · Milan, Italy · June Read more
Artificial Intelligence in Drug Discovery: A Conversation with Dekel Gelbman, CEO of FDNA
“When you talk about precision medicine every disease can become somewhat of a rare disease because you’re going to Read more
The Road to Precision Medicine: Balancing Ethics and Efficiency
Artificial intelligence has increasingly become the basis for advancing precision medicine. Tomorrow, at the ReWork Deep Learning in Healthcare Summit Read more